- Home
- CANF vs SEGG Comparison
CANF vs SEGG Comparison
Compare CANF & SEGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CANF | SEGG |
|---|---|---|
| Founded | 1994 | 2015 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 4.5M |
| IPO Year | 2011 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CANF | SEGG |
|---|---|---|
| Price | $1.44 | $1.03 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | 27.0K | ★ 1.8M |
| Earning Date | 09-08-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 70.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,779,057.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.17 | $0.42 |
| 52 Week High | $10.40 | $4.65 |
Technical Indicators
Market Signals| Indicator | CANF | SEGG |
|---|---|---|
| Relative Strength Index (RSI) | 24.58 | 38.19 |
| Support Level | N/A | $0.71 |
| Resistance Level | $3.59 | $1.59 |
| Average True Range (ATR) | 0.10 | 0.36 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 6.90 | 4.94 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About SEGG Lottery.com Inc.
Sports Entertainment Gaming Global Corp is a world-wide sports, entertainment and gaming company operating at the intersection of digital content, fan engagement and regulated gaming. It is building an integrated ecosystem designed to connect fans to the games, events and experiences it care about in compliant, technology-enabled environments. It is operated as a single-reporting unit focused on its lottery and gaming platform, and its organizational structure, internal reporting systems, and resource allocation processes were aligned accordingly. The company owns and operates three premium domain brands: Sports.com, Concerts.com, and Lottery.com representing the company's three operating focuses: Sports, Entertainment, and Gaming.